Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARC R MIYASAKI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1760644389
CMS profile
261971
Location
HONOLULU, HI

General Payments · PY2018–2024

$6,595.96

  • Reported across 351 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$861.12

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $736.30 34
Education $124.82 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $351.21 14
Lilly USA, LLC $140.27 6
Amgen Inc. $102.89 4
Acerta Pharma LLC $80.52 3
Boehringer Ingelheim Pharmaceuticals, Inc. $68.85 3
PFIZER INC. $61.05 3
Bayer HealthCare Pharmaceuticals Inc. $34.07 2
GlaxoSmithKline, LLC. $22.26 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $821.40 42
PY2019 $958.37 57
PY2020 $919.82 44
PY2021 $916.22 59
PY2022 $1,050.37 63
PY2023 $1,068.66 50
PY2024 $861.12 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $24.65 03/13/2024 Food and Beverage Undisputed 01/23/2026 1111654065 CMS
Amgen Inc. $26.43 09/04/2024 Food and Beverage Undisputed 01/23/2026 1111654067 CMS
Amgen Inc. $26.86 10/21/2024 Food and Beverage Undisputed 01/23/2026 1117330254 CMS
Amgen Inc. $24.95 12/18/2024 Food and Beverage Undisputed 01/23/2026 1111654069 CMS
AstraZeneca Pharmaceuticals LP $27.56 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105822167 CMS
AstraZeneca Pharmaceuticals LP $27.04 08/21/2024 Food and Beverage Undisputed 01/23/2026 1105708440 CMS
AstraZeneca Pharmaceuticals LP $25.92 12/20/2024 Food and Beverage Undisputed 01/23/2026 1104617082 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.68 02/07/2024 Food and Beverage Undisputed 01/23/2026 1086154968 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.39 02/15/2024 Food and Beverage Undisputed 01/23/2026 1086113544 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.71 01/17/2024 Food and Beverage Undisputed 01/23/2026 1118144046 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.88 04/08/2024 Food and Beverage Undisputed 01/23/2026 1118144048 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.26 08/02/2024 Food and Beverage Undisputed 01/23/2026 1118144044 CMS
GlaxoSmithKline, LLC. $22.26 06/14/2024 Food and Beverage Undisputed 01/23/2026 1116009815 CMS
Lilly USA, LLC $26.66 02/26/2024 Food and Beverage Undisputed 01/23/2026 1135150812 CMS
Lilly USA, LLC $20.42 02/28/2024 Food and Beverage Undisputed 01/23/2026 1135163933 CMS
Lilly USA, LLC $24.21 04/11/2024 Food and Beverage Undisputed 01/23/2026 1135150814 CMS
Lilly USA, LLC $24.80 06/19/2024 Food and Beverage Undisputed 01/23/2026 1135156715 CMS
Lilly USA, LLC $25.00 09/11/2024 Food and Beverage Undisputed 01/23/2026 1135163935 CMS
Lilly USA, LLC $19.18 10/16/2024 Food and Beverage Undisputed 01/23/2026 1135148666 CMS
Novo Nordisk Inc $24.96 01/03/2024 Food and Beverage Undisputed 01/23/2026 1096819323 CMS
Novo Nordisk Inc $6.44 01/09/2024 Food and Beverage Undisputed 01/23/2026 1097791101 CMS
Novo Nordisk Inc $8.82 01/25/2024 Education Undisputed 01/23/2026 1097428964 CMS
Novo Nordisk Inc $8.77 01/30/2024 Food and Beverage Undisputed 01/23/2026 1096991619 CMS
Novo Nordisk Inc $4.39 02/23/2024 Food and Beverage Undisputed 01/23/2026 1097412580 CMS
Novo Nordisk Inc $24.89 02/27/2024 Food and Beverage Undisputed 01/23/2026 1097546261 CMS
Novo Nordisk Inc $21.60 04/24/2024 Food and Beverage Undisputed 01/23/2026 1097250680 CMS
Novo Nordisk Inc $23.00 05/08/2024 Food and Beverage Undisputed 01/23/2026 1097129814 CMS
Novo Nordisk Inc $21.07 06/05/2024 Food and Beverage Undisputed 01/23/2026 1096908855 CMS
Novo Nordisk Inc $23.37 06/27/2024 Food and Beverage Undisputed 01/23/2026 1097641085 CMS
Novo Nordisk Inc $22.11 07/31/2024 Food and Beverage Undisputed 01/23/2026 1096686645 CMS
Novo Nordisk Inc $116.00 07/31/2024 Education Undisputed 01/23/2026 1097427810 CMS
Novo Nordisk Inc $18.46 08/28/2024 Food and Beverage Undisputed 01/23/2026 1097785844 CMS
Novo Nordisk Inc $27.33 11/13/2024 Food and Beverage Undisputed 01/23/2026 1096723463 CMS
PFIZER INC. $17.23 05/15/2024 Food and Beverage Undisputed 01/23/2026 1132006784 CMS
PFIZER INC. $20.81 08/07/2024 Food and Beverage Undisputed 01/23/2026 1132035430 CMS
PFIZER INC. $23.01 11/20/2024 Food and Beverage Undisputed 01/23/2026 1131280786 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.